Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome.
Childs Nerv Syst
; 34(4): 777-780, 2018 04.
Article
in En
| MEDLINE
| ID: mdl-29236132
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Central Nervous System Neoplasms
/
Down Syndrome
/
Carcinoma, Embryonal
/
Immunoconjugates
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Female
/
Humans
Language:
En
Journal:
Childs Nerv Syst
Journal subject:
NEUROLOGIA
/
PEDIATRIA
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: